Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese (EMBRAZE)
A Phase 2 Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Apitegromab in Overweight and Obese Adult Subjects
Sponsor: Scholar Rock, Inc.
A PHASE2 clinical study on Overweight and Obesity, this trial is completed. The trial is conducted by Scholar Rock, Inc. and has accumulated 6 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Feb 2026 — Present [monthly]
Completed PHASE2
-
Aug 2025 — Feb 2026 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Nov 2024 — Aug 2025 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — Nov 2024 [monthly]
Recruiting PHASE2
-
Aug 2024 — Sep 2024 [monthly]
Recruiting PHASE2
▶ Show 1 earlier version
-
Jul 2024 — Aug 2024 [monthly]
Recruiting PHASE2
First recorded
May 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Scholar Rock, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .